AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMBBiotechnology
+$0.25 today
- Market cap
- $286.62M
- Beta
- 2.62
- P/E (TTM)
- -7.1
- EPS (TTM)
- -$1.28
Volume 0.13M
Average 0.14M
AGMB Total Current Assets
All assets expected to be converted to cash or used up within one year.
AgomAb Therapeutics N.V. American Depositary SharesNASDAQ: AGMB
Total Current Assets · Q3 FY2025 · quarter ended Sep 2025
Total current assets of €133.01M in Q3 FY2025
Q3 FY2025 total current assets was €133.01M.
Context
- Total current assets amounted to 80.3% of total assets at the end of Q3 FY2025.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
Currency unavailable · from the balance sheet
No Total Current Assets data reported for this period type.
Total Current Assets vs competitors
How AGMB compares with its peers on the latest reported figures
- Peers report in different currencies, so total current assets is compared through growth and share of total assets rather than absolute size.
- Total current assets amounts to 80.3% of total assets for AGMB, versus a peer median of 93.8%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
ALMSAlumis Inc. Common Stock | Jun 2026 | $514.08M USD | -0.7% | +45.9% | 91.7% |
| Mar 2026 | $316.11M USD | -12.9% | -7.8% | 95.9% | |
AGMBAgomAb Therapeutics N.V. American Depositary Shares | Sep 2025 | €133.01M EUR | — | — | 80.3% |
| Mar 2026 | $110.23M USD | +1.3% | -13.2% | 55.5% | |
| Mar 2026 | $62.28M USD | +284.0% | -26.7% | 98.7% | |
ODTXOdyssey Therapeutics, Inc. | — | — | — | — | — |
| Peer median (excluding AGMB) | — | +0.3% | -10.5% | 93.8% | |
Competitors are the stored peer set for AGMB. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
AgomAb Therapeutics N.V. American Depositary Shares
NASDAQ:AGMB
Intrinsic Alpha fair value
Locked
Current Price
$5.82
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.